Response to erlotinib in a patient with lung adenocarcinoma harbouring the EML4-ALK translocation: A case report

Lung cancer is the leading cause of cancer-associated mortality worldwide, and the mainstay of treatment remains to be personalised therapy. Tyrosine kinase inhibitors of the epidermal growth factor receptor (EGFR-TKIs) have been reported to exert a significant impact in the treatment of non-small c...

Full description

Saved in:
Bibliographic Details
Published in:Oncol Lett
Main Authors: ALÌ, GRETA, CHELLA, ANTONIO, LUPI, CRISTIANA, PROIETTI, AGNESE, NICCOLI, CRISTINA, BOLDRINI, LAURA, DAVINI, FEDERICO, MUSSI, ALFREDO, FONTANINI, GABRIELLA
Format: Artigo
Language:Inglês
Published: D.A. Spandidos 2015
Subjects:
Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4356289/
https://ncbi.nlm.nih.gov/pubmed/25788996
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2015.2897
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items